BCAA vs EAA vs whey — what the leucine-threshold trials actually show

Updated 2026-05-20 · Reviewed by SupplementScore editors · No sponsorships · No affiliate links

For two decades, "BCAA" was the muscle-builder amino acid powder that won shelf space. Then a series of stable-isotope studies between 2017 and 2021 dismantled the rationale: feeding only branched-chain amino acids signals muscle protein synthesis but doesn't have the substrate to sustain it, and the trial-confirmed muscle outcomes belong to either a full essential-amino-acid (EAA) blend or — far more commonly — a complete protein like whey. This page lays out what each product actually does at the muscle, where the leucine threshold sits, when EAAs beat whey, and when none of these are worth buying.

TL;DR — which product for which job

Three things to understand before reading any product label

What "muscle protein synthesis" measures, and what it doesn't

Muscle protein synthesis (MPS) is the rate at which amino acids are incorporated into skeletal-muscle proteins, typically measured with stable-isotope-labelled amino acids over a 3–6 hour postprandial window. It's a real, validated short-term biomarker. It is not the same as long-term muscle growth. A product that raises MPS for 3 hours after one drink may not produce more lean mass after 12 weeks of training, and many do not. The serious literature uses both: acute MPS for mechanism, and 8–24 week training studies with DEXA, ultrasound or MRI for the muscle-outcome question that buyers care about [1].

The leucine threshold

Leucine — one of the three branched-chain amino acids — independently activates the mTORC1 signalling pathway that initiates MPS. Below roughly 1.7–2.5 g leucine in a single meal (the precise number depends on age and training status), MPS does not rise meaningfully above resting. Above it, MPS plateaus quickly: more leucine beyond ~3 g per meal doesn't keep raising the response [2][3]. This is the leucine threshold, and it is the central concept of modern protein nutrition. A 25 g serving of whey isolate contains ~2.5–3 g leucine and clears it. A 20 g serving of pea protein contains ~1.6 g leucine and often does not, which is why plant-based blends are sometimes leucine-enriched.

Signalling vs substrate

BCAAs alone can activate mTORC1 — they signal "build muscle." But protein synthesis needs all nine essential amino acids as substrate. If only leucine, isoleucine, and valine are in the blood, MPS rises briefly and then stalls because the cell has the signal but not the bricks. The cleanest demonstration of this is Jackman 2017, which infused stable-isotope BCAA in trained men and observed elevated MPS that was nevertheless ~22% lower than an equivalent EAA dose [4]. This is the trial that broke "BCAAs for muscle" as a credible standalone use-case.

Whey protein

Whey protein is the liquid fraction of milk after curds are removed, dried, and concentrated or isolated. A 25 g serving of whey isolate provides ~22 g protein with the highest leucine content of common dietary proteins (~10–11% by amino acid weight), a complete EAA profile, fast gastric emptying, and roughly 90% digestibility. The literature on whey for muscle outcomes is enormous: the Morton 2018 meta-analysis of 49 trials with 1,863 participants found a small but reliable effect of protein supplementation on resistance-training adaptations, with whey the most-studied form and the largest evidence base by far [1]. A 30 g per-meal whey dose produces near-maximal MPS in young adults; older adults often need 35–40 g to clear the elevated leucine threshold of anabolic resistance [5].

What whey is best for: anyone training resistance, anyone trying to hit a per-meal protein target who finds whole foods inconvenient (e.g. busy mornings, post-workout window when appetite is low), older adults with reduced food intake or appetite, and any context where cost-per-gram-of-usable-protein matters. Whey concentrate is roughly 70–80% protein; isolate is 90%+ and has less lactose (relevant for mildly lactose-intolerant users). Hydrolysate is pre-digested whey — faster absorption, marginal additional MPS benefit in healthy adults, and a meaningful price premium not warranted outside specific clinical or competitive contexts.

Adverse effects are limited: lactose-sensitivity reactions in concentrate users (largely solved by switching to isolate), occasional bloating, and the usual "expensive-pee" critique — which is mechanistically correct only when protein intake already exceeds anabolic capacity, in which case it's a sign you're overshooting, not that whey is uniquely wasteful. Renal function in healthy adults is not affected by protein intakes up to ~2.0 g/kg/day in the available trial literature.

Cost-per-30-g-protein-serving: ~$0.60–$1.50 for a verified-tested whey isolate. Lowest cost per gram of leucine of the three options here.

Essential amino acids (EAA)

EAA blends provide free-form histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, and valine — the nine amino acids the body cannot synthesise. The product class arose from clinical work in sarcopenia and ICU populations where appetite suppression and impaired digestion made high-protein meals impractical, and where smaller "compressed" doses of free EAAs could match or exceed whole-protein MPS responses per gram of nitrogen. A 10–15 g EAA dose with ~3 g leucine produces a MPS response in young adults comparable to roughly 20 g of whey [6], at meaningfully smaller volume.

What EAA is best for: people with significant whey/dairy or soy allergy who still want a leucine-loaded recovery dose; older adults with anabolic resistance and limited appetite, where a low-volume EAA before resistance exercise raises MPS more efficiently than a large whole-protein meal; and intra-workout use during long sessions where a full protein bolus is GI-uncomfortable. The clinical-nutrition population (cachexia, post-surgical, dialysis) is where the trial weight is strongest; the lifestyle-bodybuilder use case is real but narrower than marketing implies.

Where EAA is overpriced: routine recovery in healthy adults who already drink whey. Once protein intake at meals is adequate and leucine threshold is being cleared at each meal, an additional EAA dose adds little. The free-form taste is harsh — most products are heavily flavoured to mask it. Cost-per-gram of usable nitrogen runs 3–6× whey, which is the main reason whey wins for the typical recreational lifter.

Cost-per-effective-dose: $0.80–$3.00 per 10–15 g EAA serving. Higher than whey, justified primarily by allergy, appetite, or clinical context.

Branched-chain amino acids (BCAA)

BCAAs are a subset of the EAAs: leucine, isoleucine, valine, typically blended at a 2:1:1 ratio to mimic muscle composition. The product was marketed for two decades on the strength of MPS-signalling data and the (correct) observation that leucine is the most anabolic single amino acid. The leap from "leucine signals MPS" to "leucine alone, plus its two BCAA siblings, builds muscle" was always more inference than evidence, and stable-isotope trials in the late 2010s closed the gap unfavourably. Jackman 2017 found that 5.6 g BCAA produced ~22% lower mixed muscle protein synthesis than would be expected from an equivalent leucine dose in a complete EAA matrix [4]. A follow-up review in 2018 concluded that BCAA infusion alone does not stimulate maximal MPS in humans because the other six EAAs become rate-limiting — a finding that simplified the product story considerably [7].

What BCAAs remain useful for: a narrow set of contexts where a flavoured no-calorie sip during fasted training is psychologically helpful (placebo is a real performance effect), and where a small leucine bolus is added on top of an already adequate background protein intake. In hepatic encephalopathy, BCAA has specific therapeutic indications unrelated to muscle building. Outside those niches, the rational use case for BCAA monotherapy in recreational lifters has been narrowed to nearly nothing by the EAA and whey literature.

Hypothetical and real adverse effects: chronic high-dose BCAA may interfere with tryptophan and tyrosine transport across the blood-brain barrier, plausibly affecting mood or serotonin synthesis — not well-quantified in healthy adults; some animal data; not a clinically alarming signal at typical 5–10 g doses. Several observational studies have linked elevated circulating BCAA with insulin resistance in metabolic-syndrome populations; the causal direction is contested and the implication for supplementation is not settled.

Cost-per-dose: $0.30–1.20 per 5–10 g serving. The price per usable nitrogen is meaninglessly high because BCAA delivers no usable nitrogen above and beyond what an equivalent-leucine whey or EAA dose would provide more cheaply.

Head-to-head matrix

Which should you pick — decision tree

Evidence quality call-out

Whey: Tier 1. Multi-decade RCT base on muscle outcomes, large meta-analyses, broad funder mix. Effect sizes modest but reliably non-zero with resistance training [1][5].

EAA: Tier 1 for acute MPS endpoints; Tier 2 for long-duration muscle outcomes (smaller RCT base than whey, weighted toward clinical-nutrition populations) [6].

BCAA (monotherapy for muscle): Tier 3. Mechanistic studies do not translate to muscle outcomes; recent head-to-head work consistently favours EAA or whey [4][7].

BCAA (hepatic encephalopathy): Tier 1 within that specific indication. Don't confuse the populations.

Funder mix: whey trials span academic, industry (dairy councils, supplement manufacturers), and independent funders — direction-of-effect is consistent across funder types. The BCAA-vs-EAA stable-isotope work that reframed the field is largely academically funded out of UK universities (Stirling, Birmingham) with public funding [4][7]. EAA trials in older adults are weighted toward NIH/USDA funding.

Common misconceptions

"BCAAs prevent muscle breakdown during fasted training." The signal exists in animal models. In humans doing fasted resistance training, the gain over a comparable carbohydrate-only or water-only drink is small to absent in head-to-head studies, and a post-session whey dose covers the same ground at lower cost [4][7].

"You need to time protein within 30 minutes after lifting." The acute "anabolic window" has been progressively widened in the literature; the more important variable is total daily protein intake (1.4–2.0 g/kg/day for trained individuals) and adequate per-meal leucine [1]. A two-hour delay is not catastrophic.

"More protein per meal = more muscle, indefinitely." MPS plateaus at roughly 0.4 g/kg per meal in young adults and ~0.6 g/kg in older adults — beyond that, additional protein is oxidised or stored, not built [3][5]. Over the day, more protein helps until you hit ~1.6–2.0 g/kg. Beyond, returns diminish.

"Plant proteins are equivalent to whey for muscle." Not at matched gram doses. Pea, rice, hemp, and soy each have lower leucine content per gram than whey; matched-leucine doses (or 25–30% higher gram doses, or leucine-enrichment) close the gap. The 2024–2025 trial literature is increasingly aligned on this — "equivalent" is true at adequate dose, not at matched grams [8].

"Whey is bad for kidneys." In adults with normal renal function, protein intake up to ~2.0 g/kg/day produces no measurable adverse renal effect in the available RCT literature. Pre-existing kidney disease changes the picture — discuss with nephrology before any high-protein protocol.

Who should be cautious

People with chronic kidney disease (eGFR < 60) should set protein intake in consultation with a renal dietitian; high-protein supplementation may need to be capped. Adults with phenylketonuria must avoid generic EAA blends containing phenylalanine. People with maple-syrup-urine disease (a rare BCAA-metabolism disorder) must avoid BCAA supplements. Anyone on chemotherapy or under significant medical management should clear supplementation with their care team. Children and adolescents do not need any of these products at usual dietary protein intakes.

What we'd actually buy

For 95% of recreational and competitive trainees: a third-party-tested whey isolate (Informed Sport, NSF Certified for Sport, or USP), 25–30 g per dose, 1–2 doses per day to back-fill meals that fall short on protein. For dairy-allergic users or older adults with poor appetite: a leucine-enriched EAA at 10–15 g per dose, used when a full meal is impractical. Skip BCAA monotherapy unless you have a clinical indication. The combined supplementation budget for protein-related products in a typical training month should be under $35.

None of these recommendations are sponsored. Verified-tested brand options are listed on each product's individual page (look for the "Verified brands" panel).